Barinthus Biotherapeutics PLC Sponsored ADR (BRNS)
(Delayed Data from NSDQ)
$2.34 USD
-0.02 (-0.64%)
Updated May 10, 2024 03:57 PM ET
After-Market: $2.32 -0.02 (-0.64%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/10/2024
Time: -- |
3/2024 | $-0.64 | 0.00% |
Earnings Summary
For their last quarter, Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) reported earnings of -$0.45 per share, beating the Zacks Consensus Estimate of $-0.55 per share. This reflects a positive earnings surprise of 18.18%. Look out for BRNS's next earnings release expected on May 10, 2024. For the next earning release, we expect the company to report earnings of -$0.64 per share, reflecting a year-over-year decrease of 33.33%.
Earnings History
Price & Consensus
Zacks News for BRNS
Tango Therapeutics, Inc. (TNGX) Reports Q4 Loss, Lags Revenue Estimates
BRNS: What are Zacks experts saying now?
Zacks Private Portfolio Services